2015 Annual Meeting Materials

Meeting survey 


Slides from Presentations


Learning Forum


Plenary Session 1. Regulatory challenges to moving probiotics forward in the USA.


Plenary Session 2. What’s needed to translate pro/prebiotics to clinical outcomes?


Plenary Session 3. Modulating the microbiome.


Late Breaking News


Discussion Group Summary slides.

  1. Technology transfer. Chair: Michael Cabana and Eric Claassen
  2. Prebiotics and oligosaccharides in the gut: who (is enriched), what (is the effect), where (do these effects occur), and how (are these effects ultimately manifested)? Chairs: Bob Hutkins and George Fahey
  3. Potential to employ probiotics/prebiotics for fetus and infants to improve well-being. Chairs: Seppo Salminen and Gregor Reid
  4. What is the future of probiotics in the USA? Regulatory challenges. Chairs:  Dan Merenstein and Mary Ellen Sanders
  5. Intestinal barrier function – its role in GI disease, allergy, and other diseases. Chair:  Eamonn Quigley and Todd Klaenhammer
  6. The microbiome response to pre/probiotics.  Chairs:  Karen Scott and Glenn Gibson